Table 3.
Biochemical indices in experimental groups
| Control (Mean ± SD) | HF (Mean ± SD) | HFF (Mean ± SD) | HO (Mean ± SD) | |
|---|---|---|---|---|
| Bodyweight change (g) | 121.33 ± 22.92 | 151.64 ± 34.70 | 157.75 ± 22.42 | 148.01 ± 43.21 |
| FBS (mg/dl) | 145.00 ± 17.57 | 208.33 ± 50.25 ** | 214.12 ** ± 47.86 | 163.00 ± 37.40 |
| Triglyceride (mg/dl) | 91.88 ± 30.53 | 110.88 ± 12.76 | 122.37 ± 31.30 | 101.55 ± 12.08 |
| Total cholesterol (mg/dl) | 62.66 ± 7.33 | 62.00 ± 5.26 | 46.87 ± 15.42 | 56.88* ± 6.52 |
| LDL-C (mg/dl) | 12.00 ± 1.22 | 11.66 ± 2.34 | 12.37 ± 2.06 | 12.11 ± 2.42 |
| HDL-C (mg/dl) | 35.33 ± 4.76 | 32.44 ± 4.90 | 31.62 ± 5.31 | 27.77* ± 7.29 |
| AST (mg/dl) | 120.33 ± 25.91 | 170.76 ± 47.91** | 118.12 ± 17.29 | 159.34 ± 76.49 |
| ALT (mg/dl) | 44.65 ± 13.21 | 70.44 ± 9.12** | 45.12 ± 8.69 | 41.62 ± 16.74 |
| Insulin (µU/ml) | 5.50 ± 1.11 | 8.74 ± 0.99** | 7.15 ± 1.49 | 7.89** ± 0.76 |
| HOMA-IR | 1.95 ± 0.39 | 4.511.31** | 3.79** ± 1.15 | 3.20* ± 0.92 |
Kruskal–Wallis test was used for alterations between the groups
LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, AST Aspartate transaminase, ALT Alanine transaminase, HOMA-IR Homeostatic Model Assessment for Insulin Resistance
P Values < 0.05 * and < 0.01 ** compared to the control group